Payam Saadat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Payam Saadat has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Behzad Heidari
Babol University of Medical Sciences
2 shared publications- Shayan Alijanpour
Department of Nursing, School of Nursing and Midwifery, Babol University of Medical Sciences, Babol, Iran
2 shared publications A. Aman-Mohammady
Babol University of Medical Sciences
1 shared publication- Ali Bijani
Social Determinant of Health Research Center, Babol University of Medical Sciences, Babol, Iran
1 shared publication Alijan A Ahangar
Department of Neurology, Mobility Impairment Research Center, Babol University of Medical Sciences, Babol, Iran
1 shared publication- Alijan Ahmadi Ahangar
Mobility Impairment Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
1 shared publication
Latest Publications
- Open Access
- 30 June 2024
- Published by IRBIS in Epilepsy and paroxysmal conditions
- Vol. 16 (2) , 104-109
Evaluation of the effects of sodium valproate on plasma homocysteine, folate and vitamin B12 levels in epileptic patients
Objective: to investigate the effects of sodium valproate on plasma concentrations of homocysteine, folate and vitamin B12 levels in epileptic patients with long-standing tonic-clonic seizures compared to newly diagnosed epileptic patients and healthy controls.Material and methods. The study included 90 participants (mean age 36.30±12.83 years, the majority (58.89%) were males) divided into three groups: 30 non-epileptic people (control Group 1), 30 newly diagnosed epileptic patients (Group 2), and 30 patients with long-term tonic-clonic seizures epilepsy (Group 3). In Group 3, patients received sodium valproate therapy. All subjects underwent clinical and neurological examinations. Differences in plasma levels of homocysteine, folic acid and vitamin B12 in three groups were investigated after 6 months of follow-up.Results. Homocysteine level in Groups 2 and 3 was increased; for Group 2 it was significantly higher than for Groups 3 and 1 (p=0.001). Plasma folate level in Groups 2 and 3 was decreased; for Group 3 it was significantly higher than for Group 2 and lower than for Group 1 (p=0.001). Vitamin B12 level in Groups 2 and 3 was decreased, but the difference was not significant (p=0.090). In Groups 1 and 2, a significant correlation was observed between the indicators.Conclusion. Sodium valproate аdministration might disrupt the homeostatic level of homocysteine, folate and vitamin B12 and cause irregularity of their plasma contents in epileptic patients with long-standing tonic-clonic seizures.
- 30 June 2024
- Published by IRBIS in Epilepsy and paroxysmal conditions
- Vol. 16 (2) , 104-109
Open AccessEvaluation of the effects of sodium valproate on plasma homocysteine, folate and vitamin B12 levels in epileptic patients
Objective: to investigate the effects of sodium valproate on plasma concentrations of homocysteine, folate and vitamin B12 levels in epileptic patients with long-standing tonic-clonic seizures compared to newly diagnosed epileptic patients and healthy controls.Material and methods. The study included 90 participants (mean age 36.30±12.83 years, the majority (58.89%) were males) divided into three groups: 30 non-epileptic people (control Group 1), 30 newly diagnosed epileptic patients (Group 2), and 30 patients with long-term tonic-clonic seizures epilepsy (Group 3). In Group 3, patients received sodium valproate therapy. All subjects underwent clinical and neurological examinations. Differences in plasma levels of homocysteine, folic acid and vitamin B12 in three groups were investigated after 6 months of follow-up.Results. Homocysteine level in Groups 2 and 3 was increased; for Group 2 it was significantly higher than for Groups 3 and 1 (p=0.001). Plasma folate level in Groups 2 and 3 was decreased; for Group 3 it was significantly higher than for Group 2 and lower than for Group 1 (p=0.001). Vitamin B12 level in Groups 2 and 3 was decreased, but the difference was not significant (p=0.090). In Groups 1 and 2, a significant correlation was observed between the indicators.Conclusion. Sodium valproate аdministration might disrupt the homeostatic level of homocysteine, folate and vitamin B12 and cause irregularity of their plasma contents in epileptic patients with long-standing tonic-clonic seizures.
- 16 June 2023
- Published by Elsevier
- p. 561-577
Role of calcium in Parkinson's disease
- Open Access
- 1 January 2023
- Published by Apex Publishing in Scientific Journal of Kurdistan University of Medical Sciences
- Vol. 27 (6) , 97-112
The Effectiveness of Acceptance and Commitment Therapy on Pain Coping Strategies and Pain Self-efficacy in Chronic Neuropathic Pain Patients
Background and Aim:Neuropathic diseases are neurodegenerative conditions and a wide and difficult group of peripheral nerve diseases in humans. The aim of the present study was to investigate the effectiveness of acceptance and commitment therapy on pain coping strategies and pain self- efficacy in chronic neuropathic pain patients Materials and Methods: ...
- 1 January 2023
- Published by Apex Publishing in Scientific Journal of Kurdistan University of Medical Sciences
- Vol. 27 (6) , 97-112
Open AccessThe Effectiveness of Acceptance and Commitment Therapy on Pain Coping Strategies and Pain Self-efficacy in Chronic Neuropathic Pain Patients
Background and Aim:Neuropathic diseases are neurodegenerative conditions and a wide and difficult group of peripheral nerve diseases in humans. The aim of the present study was to investigate the effectiveness of acceptance and commitment therapy on pain coping strategies and pain self- efficacy in chronic neuropathic pain patients Materials and Methods: ...
- 1 July 2022
- Published by Negah Scientific Publisher in Caspian Journal of Neurological Sciences
- Vol. 8 (3) , 192-195
Immune-mediated Necrotizing Myopathy With Increased Creatine Phosphokinase and Positive Signal Recognition Particle: A Case Report
- 1 July 2022
- Published by Negah Scientific Publisher in Caspian Journal of Neurological Sciences
- Vol. 8 (3) , 192-195
Immune-mediated Necrotizing Myopathy With Increased Creatine Phosphokinase and Positive Signal Recognition Particle: A Case Report
- 17 September 2021
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 28 (29) , 5983-6010
Competing Endogenous RNAs (CeRNAs): Novel Network in Neurological Disorders
Neurological disorders (NDs) comprise a broad range of diseases affecting both central and peripheral nervous systems. These complex multifactorial diseases have a high rate of mortality all over the world, particularly in aged people. Today, new evidence drove our attention to the notable role of noncoding RNAs (ncRNAs) in the progression of NDs. Remarkably, recent studies showed that there are close communication networks among RNA transcripts such as mRNAs, long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and pseudogenes for regulating each other’s expression through competing for shared sequences in microRNAs (miRs). This concept is a new area of ongoing research recognized as competing endogenous RNA (ceRNA) hypothesis. CeRNAs are novel regulatory molecules in a wide range of biological stages and pathological contexts. Indeed, the disruption of ceRNA networks (ceRNETs) may affect neural development genes and induce neuropathological changes leading to the development of NDs. Because of this, identifying the correlation of ceRNETs with NDs will open a new window for expanding our knowledge about this field of science, as well as creating novel roads for developing specific diagnostic biomarkers for NDs management. Owing to these unique features, exploring the exact role of ceRNAs is a hot topic in NDs investigations. Hence, in this review, we will summarize the evidence supporting ceRNETs in the regulation of NDs-related gene expression.
- 17 September 2021
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 28 (29) , 5983-6010
Competing Endogenous RNAs (CeRNAs): Novel Network in Neurological Disorders
Neurological disorders (NDs) comprise a broad range of diseases affecting both central and peripheral nervous systems. These complex multifactorial diseases have a high rate of mortality all over the world, particularly in aged people. Today, new evidence drove our attention to the notable role of noncoding RNAs (ncRNAs) in the progression of NDs. Remarkably, recent studies showed that there are close communication networks among RNA transcripts such as mRNAs, long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and pseudogenes for regulating each other’s expression through competing for shared sequences in microRNAs (miRs). This concept is a new area of ongoing research recognized as competing endogenous RNA (ceRNA) hypothesis. CeRNAs are novel regulatory molecules in a wide range of biological stages and pathological contexts. Indeed, the disruption of ceRNA networks (ceRNETs) may affect neural development genes and induce neuropathological changes leading to the development of NDs. Because of this, identifying the correlation of ceRNETs with NDs will open a new window for expanding our knowledge about this field of science, as well as creating novel roads for developing specific diagnostic biomarkers for NDs management. Owing to these unique features, exploring the exact role of ceRNAs is a hot topic in NDs investigations. Hence, in this review, we will summarize the evidence supporting ceRNETs in the regulation of NDs-related gene expression.
- 9 December 2017
- Published by Springer Nature in Ageing International
- Vol. 44 (4) , 399-410
Prevalence and the Determinants of Physical Activity in an Elderly Cohort of 60 years and more. A Cross-Sectional Case-Control Study
- 9 December 2017
- Published by Springer Nature in Ageing International
- Vol. 44 (4) , 399-410
Prevalence and the Determinants of Physical Activity in an Elderly Cohort of 60 years and more. A Cross-Sectional Case-Control Study
- 31 July 2017
- Published by SAGE Publications in International Journal of Stroke
- Vol. 13 (1) , 83-86
Sex difference in types and distribution of risk factors in ischemic and hemorrhagic stroke
Background: Stroke is the second leading cause of death worldwide and is associated with several risk factors with variable risk factor distribution by population. We report the types and frequency of the associated factors of stroke in north Iran. Methods: Consecutive patients with stroke were recruited from 2014 to 2015. The two groups of ischemic and hemorrhagic stroke were compared with respect to age, sex, the prevalence, and distribution of the risk factors. Results: Among 230 patients (84.3% ischemic stroke) with mean age of 61.2 years, hypertension (73%), diabetes mellitus (53%), cardiovascular disease (51%), and dyslipidemia (47%) were the most frequent risk factors. Hypertension was significantly more prevalent in males compared with females (88% vs. 60%, OR = 4.91, 95% CI: 2.48–9.71). Hypertension, smoking, and opioid consumption were associated with hemorrhagic stroke. Dyslipidemia was significantly higher in ischemic stroke (OR = 2.65, 95% CI: 1.21–5.8). Overall, 84.3% of stroke occurred in patients aged >50 years (92.8% of women vs. 74.5% of the men, OR = 4.43, 95% CI: 1.93–10.16, p = 0.001). Conclusion: Stroke was more prevalent in females; hypertension was more prevalent in males. In the age group less than 50 years old, stroke is more prevalent in men.
- 31 July 2017
- Published by SAGE Publications in International Journal of Stroke
- Vol. 13 (1) , 83-86
Sex difference in types and distribution of risk factors in ischemic and hemorrhagic stroke
Background: Stroke is the second leading cause of death worldwide and is associated with several risk factors with variable risk factor distribution by population. We report the types and frequency of the associated factors of stroke in north Iran. Methods: Consecutive patients with stroke were recruited from 2014 to 2015. The two groups of ischemic and hemorrhagic stroke were compared with respect to age, sex, the prevalence, and distribution of the risk factors. Results: Among 230 patients (84.3% ischemic stroke) with mean age of 61.2 years, hypertension (73%), diabetes mellitus (53%), cardiovascular disease (51%), and dyslipidemia (47%) were the most frequent risk factors. Hypertension was significantly more prevalent in males compared with females (88% vs. 60%, OR = 4.91, 95% CI: 2.48–9.71). Hypertension, smoking, and opioid consumption were associated with hemorrhagic stroke. Dyslipidemia was significantly higher in ischemic stroke (OR = 2.65, 95% CI: 1.21–5.8). Overall, 84.3% of stroke occurred in patients aged >50 years (92.8% of women vs. 74.5% of the men, OR = 4.43, 95% CI: 1.93–10.16, p = 0.001). Conclusion: Stroke was more prevalent in females; hypertension was more prevalent in males. In the age group less than 50 years old, stroke is more prevalent in men.
- Open Access
- 1 January 2017
- Vol. 8 (1) , 56-58
Oral contraceptive-related transverse sinus thrombosis as an initial manifestation of antiphospholipid syndrome in the absence of systemic lupus erythematosus.
Cerebral venous sinus thrombosis is a rare and potentially life-threatening neurologic manifestation of antiphospholipid syndrome. Oral contraceptive pills (OCP) may increase the risk of vascular events, even in people without family history of venous thrombosis. A 31-year-old woman with four weeks of constant headache and history of taking OCP for one year has been selected for this study. The results of magnetic resonance imaging (MRI) of brain and venography confirmed a diagnosis of cerebral venous sinus thrombosis. The serum anticardiolipin and antiphospholipid antibodies were elevated and a definitive diagnosis of antiphospholipid syndrome was made. The present report demonstrates the importance of screening for antiphospholipid antibodies in patients presenting with cerebral venous sinus thrombosis despite history of taking OCP.
- 1 January 2017
- Vol. 8 (1) , 56-58
Open AccessOral contraceptive-related transverse sinus thrombosis as an initial manifestation of antiphospholipid syndrome in the absence of systemic lupus erythematosus.
Cerebral venous sinus thrombosis is a rare and potentially life-threatening neurologic manifestation of antiphospholipid syndrome. Oral contraceptive pills (OCP) may increase the risk of vascular events, even in people without family history of venous thrombosis. A 31-year-old woman with four weeks of constant headache and history of taking OCP for one year has been selected for this study. The results of magnetic resonance imaging (MRI) of brain and venography confirmed a diagnosis of cerebral venous sinus thrombosis. The serum anticardiolipin and antiphospholipid antibodies were elevated and a definitive diagnosis of antiphospholipid syndrome was made. The present report demonstrates the importance of screening for antiphospholipid antibodies in patients presenting with cerebral venous sinus thrombosis despite history of taking OCP.
- Open Access
- 1 January 2016
- Vol. 7 (3) , 225-227
An unusual presentation of spinal dural arteriovenous fistula: A case report
Spinal dural AVF is the most common type of spinal vascular malformation. However, presenting symptoms differ according to site of spinal involvement. This study described a case of arteriovenous malformation with paraparesis and incontinence. Diagnosis of patient was confirmed by clinical and imaging examination using magnetic resonance image and ruling out other possibilities A definitive diagnosis of arterio venous fistula was confirmed by clinical and MRI examination and demonstrated abnormalities compatible with dural arteriovenous fistula. Dural arteriovenous fistula should be considered in patients with paresis in both lower extremities.
- 1 January 2016
- Vol. 7 (3) , 225-227
Open AccessAn unusual presentation of spinal dural arteriovenous fistula: A case report
Spinal dural AVF is the most common type of spinal vascular malformation. However, presenting symptoms differ according to site of spinal involvement. This study described a case of arteriovenous malformation with paraparesis and incontinence. Diagnosis of patient was confirmed by clinical and imaging examination using magnetic resonance image and ruling out other possibilities A definitive diagnosis of arterio venous fistula was confirmed by clinical and MRI examination and demonstrated abnormalities compatible with dural arteriovenous fistula. Dural arteriovenous fistula should be considered in patients with paresis in both lower extremities.